EGFR and rectum adenocarcinoma: In this study, we evaluated EGFR expression in pre-treatment biopsy and post-treatment surgical specimens using immunohistochemistry in patients with rectal adenocarcinoma who received neoadjuvant radio- and/or chemotherapy (NRT/NRCT).